Results

Johnson & Johnson

04/19/2021 | Press release | Distributed by Public on 04/19/2021 09:47

DARZALEX® SC Becomes the First and Only Health Canada-Approved Treatment for Patients with Newly Diagnosed Light Chain (AL) Amyloidosis, A Rare Disease